Development of potential anticancer agents that target the telomere sequence

被引:8
|
作者
Park, Myunji [1 ]
Bruice, Thomas C. [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA
关键词
Telomere; Telomerase; Cancer; DEOXYNUCLEIC GUANIDINE DNG; SOLID-PHASE SYNTHESIS; DEOXYRIBONUCLEIC GUANIDINE; BINDING; LINKAGES; FIDELITY; RNA; HOMOPOLYNUCLEOTIDES; OLIGONUCLEOTIDES; CHROMOSOMES;
D O I
10.1016/j.bmcl.2010.04.089
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The immortality of cancer cells is due to the relatively high concentration of telomerase enzyme that maintains the telomere sequence during cell division. Human telomeric DNA consists of repeats of the sequence d(5'-TTAGGG-3'). Deoxyribonucleic guanidine ( DNG) is a DNA analog in which positively charged guanidine [-NH-C(=NH2+)-NH-] replaces the negatively charged phosphodiester of DNA. The synthesized DNG hexamer AgAgTgCgCpC and dodecamer AgAgTgCgCgCAgAgTgCgCpC are complementary to the non-coding telomere sequence d(5'-TTAGGG-3'). We have found that binding of the complementary DNG hexamer to the telomere is favored over that of DNA telomere by 10(2.5)-fold and binding the dodecamer with 2-mismatched DNA is favored by 10(5)-fold. We have shown that DNG binding to RNA is favored over binding to DNA. A complementary complex of DNG with RNA at the active site of telomerase enzyme would be very stable. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3982 / 3986
页数:5
相关论文
共 50 条
  • [11] TELOMERE LENGTH MAINTENANCE AS A TARGET FOR ANTICANCER DRUG DISCOVERY
    Muniyappa, K.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S28 - S29
  • [12] Design and Development of Halogenated Chalcone Derivatives as Potential Anticancer Agents
    Jain, Upendra K.
    Bhatia, Richa K.
    Rao, Akkinepally R.
    Singh, Ranjit
    Saxena, Ajit K.
    Sehar, Irum
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (01) : 73 - 80
  • [13] Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
    Smart, DDK
    Ortiz, KL
    Mattson, D
    Bradbury, CM
    Bisht, KS
    Sieck, LK
    Brechbiel, MW
    Gius, D
    CANCER RESEARCH, 2004, 64 (18) : 6716 - 6724
  • [14] The development of anticancer agents
    Connors, TA
    NATIONAL MEDICAL JOURNAL OF INDIA, 1997, 10 (06): : 259 - 261
  • [15] Peptides as Potential Anticancer Agents
    Aaghaz, Shams
    Gohel, Vivek
    Kamal, Ahmed
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (17) : 1491 - 1511
  • [16] SYNTHESIS OF POTENTIAL ANTICANCER AGENTS
    WILLIAMS.CE
    SAYERS, TJ
    SELIGMAN, AM
    WITTEN, B
    JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (03) : 511 - &
  • [17] Cannabinoids:: Potential anticancer agents
    Guzmán, M
    NATURE REVIEWS CANCER, 2003, 3 (10) : 745 - 755
  • [18] PIPERIDONES AS POTENTIAL ANTICANCER AGENTS
    RAM, VJ
    PANDEY, HN
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 1974, 51 (10) : 878 - 879
  • [19] Imidazoles as potential anticancer agents
    Ali, Imran
    Lone, Mohammad Nadeem
    Aboul-Enein, Haasan Y.
    MEDCHEMCOMM, 2017, 8 (09) : 1742 - 1773
  • [20] Bacteriocins as Potential Anticancer Agents
    Kaur, Sumanpreet
    Kaur, Sukhraj
    FRONTIERS IN PHARMACOLOGY, 2015, 6